ArticleEuropean journal of medical research2025
Evaluation of patient satisfaction and influencing factors in the treatment of striae distensae with novel growth factor-based serum.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Striae distensae, commonly known as stretch marks, are dermal scars resulting from excessive skin stretching and structural remodeling. Despite numerous treatment modalities, patient satisfaction varies significantly, and effective management remains a challenge. This study aimed to evaluate patient satisfaction with novel serum containing amino acids, vitamins, and growth factors for the treatment of striae distensae and to assess the impact of individual characteristics, lesion aspects, and patient habits on treatment outcomes. A total of 156 patients underwent MN-assisted application of the serum. Treatment frequency and duration were determined by physicians on the basis of individual response. Patients completed an online questionnaire assessing demographics, lesion characteristics, lifestyle habits, and satisfaction via the customer satisfaction score (CSAT). Data were analyzed to identify factors influencing treatment satisfaction. Overall, 82.4% of patients were very satisfied, and 78.4% reported significant improvement in striae appearance. Satisfaction was highest in younger patients (≤ 44 years), those with newer striae, and nonsmokers. Patients with medium skin tones reported greater satisfaction than did those with very fair or dark brown/black skin tones. Most patients (65%) required only one treatment session to observe improvements, and 72% noticed visible results within two weeks. Adverse effects were minimal, affecting only 8.4% of the participants. The serum demonstrated high patient satisfaction and rapid improvement in the striae distensae. Factors such as age, striae duration, smoking, and skin tone influenced treatment outcomes. These findings support the importance of personalized treatment approaches for optimal results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.